microcirculatory perfusion in living kidney donors

microcirculatory perfusion in living kidney donors - microLINKED

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON46695

Enrollment

Registered

2018-05-23

Start date

2018-06-25

Completion date

Unknown

Last updated

2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age > 18 Living kidney donors Provision of written informed consent

Exclusion criteria

Exclusion criteria: If candidate cannot understand Dutch or English.

Design outcomes

Primary

Measure	Time frame
The main endpoint is to assess if perfused vessel density (PVD) in living kidney donors will be decreased after donation	—

Secondary

Measure	Time frame
1) total vessel density (TVD) 2) eGFR 3) serum RAAS markers (aldosterone/renine ratio), FGF-23, insulin resistance markers (HOMA-IR), inflammation markers (hs-CRP and IL-6) levels	—

Countries

Netherlands

Outcome results